BIVI
Biovie Inc
NASDAQ: BIVI · HEALTHCARE · BIOTECHNOLOGY
$1.65
+4.43% today
Updated 2026-04-30
Market cap
$11.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.28
Dividend yield
—
52W range
$1 – $13
Volume
0.1M
Biovie Inc (BIVI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-10040.00 | $-172832.00 | $-65383.00 | $-163631.00 | $-623615.00 | $-621341.00 | $-2.50M | $-1.63M | $-10.45M | $-18.99M | $-40.25M | $-27.95M | $-19.03M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.00 | $0.00 | $0.00 | $4.00 | $5.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $2589.00 | $7500.00 | $7875.00 | $92052.00 | $893484.00 | $64860.00 | $24846.00 | $3.02M | $6.19M | $6.38M | $4.66M | $2.47M |
| Free cash flow | $-10040.00 | $-172832.00 | $-65383.00 | $-163631.00 | $-623615.00 | $-621341.00 | $-2.50M | $-1.63M | $-10.45M | $-18.99M | $-40.25M | $-27.95M | $-19.03M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $48659.00 | $17.10M | $53.60M | — | — | $886423.00 | $369.46B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | $14.13M | — | — | — |